Sanofi has announced that its two combination vaccine candidates have received fast track status from the US FDA.
The US Food and Drug Administration(FDA) has granted Fast Track designation to two non-mRNA combination vaccine candidates ...
Most positive tests for RSV so far this season in Canada have been among the youngest, federal data says. And while Health ...
On 11 December 2024, the High Court handed down its judgment in Commonwealth of Australia v Sanofi [2024] HCA 47, bringing the long-running damages dispute between the Commonwealth and Sanofi to an ...
The FDA bestows a Fast Track designation to Sanofi's two combination vaccine candidates to prevent influenza and COVID-19 infections.
US FDA grants fast track designation to two Sanofi’s combination vaccine candidates to prevent influenza & Covid-19 infections: Paris Thursday, December 12, 2024, 10:00 Hrs [IST ...
Innovations in rare blood disorders took center stage at the 2024 American Society of Hematology (ASH) Annual Meeting & ...
The US Food and Drug Administration has granted Fast Track designation to two Sanofi combination vaccine candidates to prevent influenza and COVID-19 infections in individuals 50 years of age and ...
Novavax is working with the FDA to explore a pathway for accelerated approval of the COVID-19-flu combination and standalone ...
Dupilumab treatment improves signs and symptoms of atopic dermatitis (AD) in young children, according to a study published ...
Pharmaceutical and biotech businesses were enthusiastic about the UPC before the court opened, but so far there has only been ...
More and more people under 50 have been diagnosed with bowel cancer in different parts of the world over the past few decades ...